Brief: Vicore Pharma Q3 EBIT SEK -65.1 Million
02/11/2023 07:00
Nov 02 (Reuters) - Vicore Pharma Q3 sales SEK 0. * Q3 adjusted EPS SEK -0.58 * Q3 net income SEK -63.6 million * Q3 adjusted free cash flow SEK -35.4 million * Q3 cash & investments SEK 551.5 million
Recent news on Vicore Pharma Holding AB
See all newsBrief: Vicore Pharma Holding Q3 Net Revenues Amounted To Sek 0.6 Mln
Brief: Vicore Pharma Holding AB Phase 2B Aspire Trial Of Buloxibutid In Ipf Passes Pre-Planned Futility Analysis, On Track For Mid-2027 Topline Results
Brief: Vicore Pharma Q2 Operating Loss At SEK 150.1 Million
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:53 PM
Brief: Vicore Pharma Shares Start Trading In US On July 2